Survival and prognostic factors in pediatric osteosarcoma: A 5-year single-center experience in Central Java, Indonesia
Background The advent of chemotherapy with multimodal treatment has improved the survival rate of osteosarcoma. However, the survival rate of patients with osteosarcoma in low- and middle-income countries (LMICs) remains lower than in high-income countries (HICs). Objective To assess prognostic f...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Indonesian Pediatric Society Publishing House
2024-02-01
|
| Series: | Paediatrica Indonesiana |
| Subjects: | |
| Online Access: | https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/3448 |
| _version_ | 1797263547233730560 |
|---|---|
| author | Muhammad Riza Harsono Salimo Brian Wasita Mujaddid Idulhaq Rhyan Darma Saputra Vitri Widyaningsih Soestrisno Soestrisno Fairuz Zahidah Janur Wayanshakty |
| author_facet | Muhammad Riza Harsono Salimo Brian Wasita Mujaddid Idulhaq Rhyan Darma Saputra Vitri Widyaningsih Soestrisno Soestrisno Fairuz Zahidah Janur Wayanshakty |
| author_sort | Muhammad Riza |
| collection | DOAJ |
| description | Background The advent of chemotherapy with multimodal treatment has improved the survival rate of osteosarcoma. However, the survival rate of patients with osteosarcoma in low- and middle-income countries (LMICs) remains lower than in high-income countries (HICs).
Objective To assess prognostic factors associated with survival rate of pediatric patients with osteosarcoma in Moewardi Hospital, Surakarta.
Methods This retrospective study was performed in pediatric osteosarcoma patients at Moewardi Hospital, Surakarta from 2018 to 2022. We described patients’ clinical presentations and assessed prognostic factors. Survival rate was calculated using Kaplan–Meier survival analysis. Prognostic factors were analyzed using univariate and multivariate Cox regression methods.
Results Of the 82 patients included in the study, 40 (48.8%) were male and 42 (51.2%) were female. Most subjects (75.6%) were diagnosed with osteosarcoma at the age of >10 years, 45 patients (54.9%) had primary tumors in the femur, and 16 patients (19.5%) had limb salvage surgery. The mean event-free survival duration was 13.6 (95%CI 9.7 to 17.5) months. The mean duration of overall survival was 22.7 (95%CI 17.3 to 28.1) months, with a 44.1% survival probability. Type of surgery was a significant prognostic factor (P=0.018), with limb salvage having better survival probability (93.3%) than amputation (19.8%).
Conclusion The overall survival rate of osteosarcoma patients at our center is still lower than in other regional centers. Limb salvage surgery was a significant prognostic factor for survival, while gender, location of primary tumor, histological subtype, and metastasis at the time of diagnosis were not. |
| first_indexed | 2024-04-25T00:14:44Z |
| format | Article |
| id | doaj.art-9ce730e7adec4a829a42e396e831db56 |
| institution | Directory Open Access Journal |
| issn | 0030-9311 2338-476X |
| language | English |
| last_indexed | 2024-04-25T00:14:44Z |
| publishDate | 2024-02-01 |
| publisher | Indonesian Pediatric Society Publishing House |
| record_format | Article |
| series | Paediatrica Indonesiana |
| spelling | doaj.art-9ce730e7adec4a829a42e396e831db562024-03-13T05:20:45ZengIndonesian Pediatric Society Publishing HousePaediatrica Indonesiana0030-93112338-476X2024-02-0164110610.14238/pi64.1.2024.10-63448Survival and prognostic factors in pediatric osteosarcoma: A 5-year single-center experience in Central Java, IndonesiaMuhammad Riza0Harsono Salimo1Brian Wasita2Mujaddid Idulhaq3Rhyan Darma Saputra4Vitri Widyaningsih5Soestrisno Soestrisno6Fairuz Zahidah7Janur Wayanshakty8Department of Child Health, Faculty of Medicine, Sebelas Maret University/Dr. Moewardi Hospital, Surakarta, Central JavaDepartment of Child Health, Faculty of Medicine, Universitas Sebelas Maret/Dr. Moewardi Hospital, Surakarta, Central JavaDepartment of Anatomical Pathology, Faculty of Medicine, Universitas Sebelas Maret/Dr. Moewardi Hospital, Surakarta, Central JavaDepartment of Orthopedics and Traumatology, Universitas Sebelas Maret, Surakarta, Central JavaDepartment of Orthopedics and Traumatology, Universitas Sebelas Maret and Prof. Dr. R. Soeharso Orthopedics Hospital, Surakarta, Central JavaDepartment of Public Health, Faculty of Medicine, Faculty of Medicine, Universitas Sebelas Maret/Dr. Moewardi Hospital, Surakarta, Central JavaDepartment of Obstetrics and Gynecology, Faculty of Medicine, Universitas Sebelas Maret/Dr. Moewardi Hospital, Surakarta, Central JavaDepartment of Child Health, Faculty of Medicine, Universitas Sebelas Maret/Dr. Moewardi Hospital, Surakarta, Central JavaDepartment of Child Health, Faculty of Medicine, Sebelas Maret University/Dr. Moewardi Hospital, Surakarta, Central JavaBackground The advent of chemotherapy with multimodal treatment has improved the survival rate of osteosarcoma. However, the survival rate of patients with osteosarcoma in low- and middle-income countries (LMICs) remains lower than in high-income countries (HICs). Objective To assess prognostic factors associated with survival rate of pediatric patients with osteosarcoma in Moewardi Hospital, Surakarta. Methods This retrospective study was performed in pediatric osteosarcoma patients at Moewardi Hospital, Surakarta from 2018 to 2022. We described patients’ clinical presentations and assessed prognostic factors. Survival rate was calculated using Kaplan–Meier survival analysis. Prognostic factors were analyzed using univariate and multivariate Cox regression methods. Results Of the 82 patients included in the study, 40 (48.8%) were male and 42 (51.2%) were female. Most subjects (75.6%) were diagnosed with osteosarcoma at the age of >10 years, 45 patients (54.9%) had primary tumors in the femur, and 16 patients (19.5%) had limb salvage surgery. The mean event-free survival duration was 13.6 (95%CI 9.7 to 17.5) months. The mean duration of overall survival was 22.7 (95%CI 17.3 to 28.1) months, with a 44.1% survival probability. Type of surgery was a significant prognostic factor (P=0.018), with limb salvage having better survival probability (93.3%) than amputation (19.8%). Conclusion The overall survival rate of osteosarcoma patients at our center is still lower than in other regional centers. Limb salvage surgery was a significant prognostic factor for survival, while gender, location of primary tumor, histological subtype, and metastasis at the time of diagnosis were not.https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/3448osteosarcoma; pediatric; survival rate; low- and middle-income countries |
| spellingShingle | Muhammad Riza Harsono Salimo Brian Wasita Mujaddid Idulhaq Rhyan Darma Saputra Vitri Widyaningsih Soestrisno Soestrisno Fairuz Zahidah Janur Wayanshakty Survival and prognostic factors in pediatric osteosarcoma: A 5-year single-center experience in Central Java, Indonesia Paediatrica Indonesiana osteosarcoma; pediatric; survival rate; low- and middle-income countries |
| title | Survival and prognostic factors in pediatric osteosarcoma: A 5-year single-center experience in Central Java, Indonesia |
| title_full | Survival and prognostic factors in pediatric osteosarcoma: A 5-year single-center experience in Central Java, Indonesia |
| title_fullStr | Survival and prognostic factors in pediatric osteosarcoma: A 5-year single-center experience in Central Java, Indonesia |
| title_full_unstemmed | Survival and prognostic factors in pediatric osteosarcoma: A 5-year single-center experience in Central Java, Indonesia |
| title_short | Survival and prognostic factors in pediatric osteosarcoma: A 5-year single-center experience in Central Java, Indonesia |
| title_sort | survival and prognostic factors in pediatric osteosarcoma a 5 year single center experience in central java indonesia |
| topic | osteosarcoma; pediatric; survival rate; low- and middle-income countries |
| url | https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/3448 |
| work_keys_str_mv | AT muhammadriza survivalandprognosticfactorsinpediatricosteosarcomaa5yearsinglecenterexperienceincentraljavaindonesia AT harsonosalimo survivalandprognosticfactorsinpediatricosteosarcomaa5yearsinglecenterexperienceincentraljavaindonesia AT brianwasita survivalandprognosticfactorsinpediatricosteosarcomaa5yearsinglecenterexperienceincentraljavaindonesia AT mujaddididulhaq survivalandprognosticfactorsinpediatricosteosarcomaa5yearsinglecenterexperienceincentraljavaindonesia AT rhyandarmasaputra survivalandprognosticfactorsinpediatricosteosarcomaa5yearsinglecenterexperienceincentraljavaindonesia AT vitriwidyaningsih survivalandprognosticfactorsinpediatricosteosarcomaa5yearsinglecenterexperienceincentraljavaindonesia AT soestrisnosoestrisno survivalandprognosticfactorsinpediatricosteosarcomaa5yearsinglecenterexperienceincentraljavaindonesia AT fairuzzahidah survivalandprognosticfactorsinpediatricosteosarcomaa5yearsinglecenterexperienceincentraljavaindonesia AT janurwayanshakty survivalandprognosticfactorsinpediatricosteosarcomaa5yearsinglecenterexperienceincentraljavaindonesia |